ganciclovir evaluation in aids patients with cytomegalovirus retinitis: a european study of treatment patterns and resource utilization.

NLM AIDSLINE Ganciclovir evaluation in AIDS patients with cytomegalovirus retinitis: a European study of treatment patterns and resource utilization. Hardens M
July 30, 1997

AIDS. 1996 Dec;10 Suppl 4:S25-30. Unique Identifier : AIDSLINE OBJECTIVE: To describe the treatment patterns for intravenous ganciclovir induction and maintenance therapy in AIDS patients with cytomegalovirus (CMV) retinitis in five European countries and to investigate the anticipated impact of oral ganciclovir on resource utilization during maintenance. DESIGN: Study was a retrospective analysis based on a prospective randomized clinical trial (AV1034) comparing the efficacy of oral versus intravenous ganciclovir in CMV retinitis maintenance therapy. Resource utilization patterns for ganciclovir induction and maintenance, retinitis progression and management and treatment of adverse events were based on clinical trial data and interviews with local experts involved in treatment of patients with CMV retinitis. RESULTS: Oral ganciclovir maintenance was effective, although associated with a faster time to progression, compared to intravenous ganciclovir. There was considerable variation in the treatment patterns for induction with intravenous ganciclovir in the different countries. Most inductions were achieved with a central intravenous line, also used in subsequent intravenous maintenance therapy, usually performed on an outpatient or day care inpatient basis. Intravenous maintenance therapy was identified as a large resource utilization which would decrease considerably with the introduction of oral ganciclovir. In addition, decreased incidence of adverse side effects with oral ganciclovir would also lead to decreased resource use. CONCLUSIONS: Introduction of oral ganciclovir is expected to lead to significant reduction in resource use and may avoid the need for central line placement. This, and the lower incidence of adverse side effects, normally associated with intravenous ganciclovir, are also expected to lead to improvement in the patient's quality of life. Antiviral Agents/THERAPEUTIC USE AIDS-Related Opportunistic Infections/DRUG THERAPY Cytomegalovirus Retinitis/DRUG THERAPY Ganciclovir/THERAPEUTIC USE Physician's Practice Patterns Utilization Review

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV No time to lose in the search for an HIV vaccine India Widens Price Control Over Medicines Health group didn't disclose HIV tests, apologizes As Hepatitis C Spreads, Scotland Steps In Russia has 'no anti-AIDS strategy': official Uganda: Over 600 Circumcised in Masaka 1 new hepatitis case in Okla. public health scare NEW JERSEY: Drug Company Donates Thousands to HIV/AIDS Orgs Russia has 'no anti-AIDS strategy': official NEW JERSEY: Drug Company Donates Thousands to HIV/AIDS Orgs CALIFORNIA: Giants, Nonprofit Mark 20 Years of AIDS Awareness UNITED STATES: New AIDS Group Debuts as NAPWA Successor Viet Nam: South-South learning helps prepare for sustainable provision of AIDS treatment CALIFORNIA: NorCal AIDS Cycle Opening and Closing Ceremonies Show Support For Bicyclists SOUTH AFRICA: AIDS-Related Deaths Falling in S. Africa: Agency CALIFORNIA: Oakland HIV/AIDS Housing the Focus of Meeting CALIFORNIA: Cedars-Sinai Cuts HIV/AIDS Services GUAM: National Asian and Pacific Islander HIV/AIDS Awareness Day
Information in this article was accurate in July 30, 1997. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.